Dominick Colangelo
Chief Executive Officer bij VERICEL CORPORATION
Vermogen: 11 M $ op 31-03-2024
Actieve functies van Dominick Colangelo
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
VERICEL CORPORATION | Director/Board Member | 01-03-2013 | - |
Chief Executive Officer | 01-03-2013 | - | |
President | 01-03-2013 | - | |
TREVI THERAPEUTICS, INC. | Director/Board Member | 29-06-2020 | - |
Independent Dir/Board Member | 29-06-2020 | - |
Loopbaan van Dominick Colangelo
Eerdere bekende functies van Dominick Colangelo
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Promedior, Inc.
Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA. | Director/Board Member | 23-02-2011 | 15-05-2012 |
Chief Executive Officer | 01-12-2008 | 15-05-2012 | |
President | 01-12-2008 | 15-05-2012 | |
Oscient Pharmaceuticals Corp.
Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Chief Operating Officer | 01-01-2005 | 11-12-2008 |
LV Management Group, LLC
LV Management Group, LLC Investment ManagersFinance Lilly Ventures Management Group LLC (Lilly ventures) is a venture capital firm, a subsidiary of Eli Lilly & Co. founded in 2001 by S.Edward Torres and Ron Laufer. The firm is headquartered in Indianapolis,Indiana. | Chief Investment Officer | - | 07-12-2005 |
Private Equity Investor | - | 07-12-2005 | |
ELI LILLY AND COMPANY | Corporate Officer/Principal | 01-01-1995 | - |
Opleiding van Dominick Colangelo
State University of New York at Buffalo | Undergraduate Degree |
Duke University School of Law | Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 9 |
Operationeel
Director/Board Member | 3 |
Chief Executive Officer | 2 |
President | 2 |
Sectoraal
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
VERICEL CORPORATION | Health Technology |
TREVI THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Oscient Pharmaceuticals Corp.
Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Commercial Services |
LV Management Group, LLC
LV Management Group, LLC Investment ManagersFinance Lilly Ventures Management Group LLC (Lilly ventures) is a venture capital firm, a subsidiary of Eli Lilly & Co. founded in 2001 by S.Edward Torres and Ron Laufer. The firm is headquartered in Indianapolis,Indiana. | Finance |
Promedior, Inc.
Promedior, Inc. Medical SpecialtiesHealth Technology Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA. | Health Technology |
- Beurs
- Insiders
- Dominick Colangelo
- Ervaring